Zeqian Li

Title: Celebrating the Innovations of Inventor Zeqian Li

Introduction: Zeqian Li, an accomplished inventor based in Kunming, China, has made significant contributions to the field of medicinal chemistry. With a focus on innovative pharmaceuticals, Li has a patent that highlights his dedication to developing effective treatments for mood disorders.

Latest Patents: Zeqian Li holds a patent for a polymorph of triaryldimethylpiperazine dihydrochloride. The patent discloses five polymorph forms labeled B, P, F, J, and O of the compound (4-((R)-((2S,5R)-4-(3-fluorobenzyl)-(2,5-dimethylpiperazine-1-yl)(3-hydroxyphenyl)methyl)phenyl)(4-methylpiperidine-1-yl)methanone dihydrochloride. This invention includes preparation methods and applications in manufacturing a medicament aimed at preventing or treating mood disorders or diseases associated with the δ opioid receptor.

Career Highlights: Zeqian Li works at the Yunnan Institute of Materia Medica, where he has contributed to various research initiatives focused on pharmaceutical development. His work reflects a strong commitment to improving mental health through innovative medicinal compounds.

Collaborations: Throughout his career, Zeqian Li has collaborated with notable coworkers, including Jingkun Wang and Zhaoyun Zhu. These partnerships have aided in the research and development of his patented work, further enhancing the potential impact of his inventions in the medical field.

Conclusion: Zeqian Li's innovative approach to pharmaceutical chemistry and his focus on developing new treatments for mood disorders exemplify the importance of inventors in the medical landscape. His contributions to the field, secured by his patent, position him as a key figure in advancing health solutions and improving patient care.